Influenza vaccination in patients with cancer: An overview

ONCOLOGY

Volumn 24, Issue 12, 2010, Pages

  Boehmer, Leagh M ^a   Waqar, Saima N ^b   Govindan, Ramaswamy ^b  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIFLU; CORTICOSTEROID; FLULAVAL; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; OSELTAMIVIR; UNCLASSIFIED DRUG; VIRUS SIALIDASE; ZANAMIVIR;

ACTIVE IMMUNIZATION; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MORBIDITY; MORTALITY; NONHUMAN; REVIEW; RISK REDUCTION; SOLID TUMOR; VIRUS REPLICATION;

EID: 78649668524     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009;58:1-52.
2. Fitzgerald DA. Human swine influenza A [H1N1]: practical advice for clinicians early in the pandemic. Paediatr Respir Rev. 2009;10:154-8.
3. Engelhard D, Nagler A, Hardan I, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant. 1993;11:1-5.
4. Anderson H, Petrie K, Berrisford C, et al. Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer. 1999;80:219-20.
5. Greenberg ME, Lai MH, Hartel GF, et al. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine - preliminary report. N Engl J Med. 2009;361:2405-13.
6. Zhu FC, Wang H, Fang HH, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med. 2009;361:2414-23.
7. Finelli Lea. Update: influenza activity - United States, April. MMWR 58:1009-12, August 2009
8. Ganz PA, Shanley JD, Cherry JD. Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer. 1978;42:2244-7.
9. Centers for Disease Control and Prevention. Recommendations for using TIV and LAIV during the 2010-11 influenza season. Available from: http://www. cdc.gov/flu/professionals/acip/recommendations.htm.
10. Ring A, Marx G, Steer C, et al. Influenza vaccination and chemotherapy: a shot in the dark? Support Care Cancer. 2002;10:462-5.
11. Ortbals DW, Liebhaber H, Presant CA, et al. Influenza immunization of adult patients with malignant diseases. Ann Intern Med. 1977;87:552-7.
12. Noah DL, Hill H, Hines D, et al. Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure. Clin Vaccine Immunol. 2009;16:558-66.
13. Pederson J. Hemagglutination-inhibition test for avian influenza virus subtype identification and the detection and quantitation of serum antibodies to the avian influenza virus. Totowa, NJ: Humana Press; 2008.
14. Katz J, Hancock K, Veguilla V, et al. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR. 2009;58:521-4.
15. Vilar-Compte D, Cornejo P, Valle-Salinas A, et al. Influenza vaccination in patients with breast cancer: a case-series analysis. Med Sci Monit. 2006;12:CR332-6.
16. Nordoy T, Aaberge IS, Husebekk A, et al. Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol. 2002;19:71-8.
17. Mazza JJ, Yale SH, Arrowood JR, et al. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res. 2005;3:214-20.
18. Lo W, Whimbey E, Elting L, et al. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis. 1993;12:778-82.
19. Robertson JD, Nagesh K, Jowitt SN, et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer. 2000;82:1261-5.
20. Gross PA, Gould AL, Brown AE. Effect of cancer chemotherapy on the immune response to influenza virus vaccine: review of published studies. Rev Infect Dis. 1985;7:613-8.
21. Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Available from: http://www.cdc.gov/h1n1flu/recommendations.htm.